Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome

Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome

US Patent 11083745 · Granted Aug 10, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

OPA1 antisense oligomers for treatment of conditions and diseases2025
Methods and compositions for treatment of cholesteryl ester storage disease2024
Antisense oligomers for treatment of conditions and diseases2024
OPA1 antisense oligomers for treatment of conditions and diseases2023
Reducing nonsense-mediated MRNA decay2022
Reducing nonsense-mediated MRNA decay2022
Antisense compounds and uses thereof2022
Antisense oligomers and uses thereof2021
Antisense oligomers and uses thereof2021
Antisense oligomers and uses thereof2021
Compositions and methods for modulation of IKBKAP splicing2021
Peptidomimetic macrocycles2021